A Novel Cardioprotective Agent in Cardiac Transplantation: Metformin Activation of AMP-Activated Protein Kinase Decreases Acute Ischemia-Reperfusion Injury and Chronic Rejection

The main cause of mortality after the first year from cardiac transplantation is cardiac allograft vasculopathy (CAV), which leads to chronic rejection of the heart. To improve long-term outcomes in cardiac transplantation, treatments to prevent or diminish CAV are actively being researched. Ischemi...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Chin, Jocelyn T., Troke, Joshua J., Kimura, Naoyuki, Itoh, Satoshi, Wang, Xi, Palmer, Owen P., Robbins, Robert C., Fischbein, Michael P.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: YJBM 2011
Konular:
Original Contribution
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3238328/
https://ncbi.nlm.nih.gov/pubmed/22180679
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller